Header Logo

Fadi Chalhoub

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pacemaker, Artificial
3
2023
42
2.400
 Why?
Catheter Ablation
4
2022
138
0.900
 Why?
Syncope, Vasovagal
1
2023
8
0.870
 Why?
High-Frequency Jet Ventilation
1
2022
2
0.790
 Why?
High-Frequency Ventilation
1
2022
5
0.790
 Why?
Atrial Fibrillation
5
2022
798
0.670
 Why?
Patient Discharge
1
2022
479
0.630
 Why?
Cardiac Pacing, Artificial
3
2023
34
0.620
 Why?
Anticoagulants
3
2022
487
0.240
 Why?
Treatment Outcome
5
2022
5183
0.230
 Why?
Hypotension
1
2024
47
0.220
 Why?
Body Surface Potential Mapping
2
2013
4
0.210
 Why?
Equipment Design
2
2022
317
0.210
 Why?
Heart Conduction System
2
2013
49
0.210
 Why?
Equipment Failure
1
2022
65
0.200
 Why?
Tidal Volume
1
2022
36
0.200
 Why?
Hypertension
2
2024
601
0.170
 Why?
Prospective Studies
3
2022
3101
0.150
 Why?
Humans
9
2024
59491
0.150
 Why?
Pandemics
1
2022
608
0.150
 Why?
Thromboembolism
2
2014
70
0.130
 Why?
Middle Aged
6
2024
16274
0.110
 Why?
Thiophenes
1
2014
43
0.110
 Why?
Morpholines
1
2014
86
0.110
 Why?
Cardiac Catheters
1
2012
8
0.100
 Why?
Electrodes, Implanted
1
2012
38
0.100
 Why?
Heart Atria
1
2013
138
0.100
 Why?
beta-Alanine
1
2012
9
0.100
 Why?
Registries
2
2014
803
0.100
 Why?
Aged
4
2022
13339
0.100
 Why?
Benzimidazoles
1
2012
59
0.090
 Why?
Image Enhancement
1
2012
190
0.090
 Why?
Warfarin
1
2012
109
0.090
 Why?
Imaging, Three-Dimensional
1
2013
265
0.090
 Why?
Software
1
2013
367
0.080
 Why?
Algorithms
1
2013
989
0.070
 Why?
Feasibility Studies
3
2014
524
0.070
 Why?
Angiotensinogen
1
2024
3
0.060
 Why?
Antihypertensive Agents
1
2024
172
0.050
 Why?
Double-Blind Method
1
2024
680
0.050
 Why?
Blood Pressure
1
2024
522
0.050
 Why?
RNA Interference
1
2024
590
0.040
 Why?
RNA
1
2024
404
0.040
 Why?
Sensitivity and Specificity
2
2013
1095
0.040
 Why?
Male
5
2024
27559
0.040
 Why?
Reproducibility of Results
2
2013
1551
0.040
 Why?
Follow-Up Studies
2
2014
2329
0.040
 Why?
Female
5
2024
30906
0.040
 Why?
Postoperative Complications
2
2014
1134
0.030
 Why?
Perioperative Period
1
2014
20
0.030
 Why?
Rivaroxaban
1
2014
21
0.030
 Why?
Factor Xa Inhibitors
1
2014
36
0.030
 Why?
Administration, Oral
1
2014
344
0.030
 Why?
Equipment Failure Analysis
1
2012
73
0.030
 Why?
Dose-Response Relationship, Drug
1
2014
809
0.020
 Why?
Dabigatran
1
2012
23
0.020
 Why?
Swine
1
2012
344
0.020
 Why?
Anti-Arrhythmia Agents
1
2012
93
0.020
 Why?
Secondary Prevention
1
2012
153
0.020
 Why?
Perioperative Care
1
2012
77
0.020
 Why?
Hemorrhage
1
2012
277
0.020
 Why?
Sex Factors
1
2012
960
0.020
 Why?
Electrocardiography
1
2012
524
0.020
 Why?
Echocardiography
1
2012
459
0.020
 Why?
Incidence
1
2012
1237
0.020
 Why?
Age Factors
1
2012
1518
0.020
 Why?
Adult
1
2024
15782
0.020
 Why?
Retrospective Studies
1
2012
6007
0.010
 Why?
Animals
1
2012
19647
0.010
 Why?
Chalhoub's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_